| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 620.9K | $79.68M | - | |
| CEO | 140.4K | $18.02M | - | |
| Other | 52.8K | $6.77M | - | |
| Other | 46.8K | $6.00M | - | |
| Other | 26.9K | $3.45M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2017 | Bozigian Haig P. | Chief Development Officer | Sale+OE | 22,500 | $50.00 | $1,125,000.00 | -8.0% | |
| Jul 27, 2017 | OBrien Christopher Flint | Chief Medical Officer | Sale+OE | 8,734 | $50.00 | $436,700.00 | -15.1% | |
| May 23, 2017 | Grigoriadis Dimitri E. | Chief Research Officer | Sell | 10,000 | $53.39 | $533,900.00 | -8.5% | |
| May 19, 2017 | Lloyd-Smith Malcolm | Chief Regulatory Officer | Sale+OE | 9,960 | $53.63 | $534,154.80 | -27.7% | |
| May 18, 2017 | Lippoldt Darin | Chief Legal Officer | Sale+OE | 10,000 | $53.27 | $532,700.00 | -43.2% | |
| May 18, 2017 | OBrien Christopher Flint | Chief Medical Officer | Sale+OE | 105,634 | $53.32 | $5,632,404.88 | -68.3% | |
| May 5, 2017 | Nevinny Corinne H | Director | Sell | 5,000 | $53.98 | $269,900.00 | -12.6% | |
| May 2, 2017 | GORMAN KEVIN CHARLES | Chief Executive Officer | Sale+OE | 21,739 | $53.23 | $1,157,166.97 | -6.1% | |
| May 2, 2017 | Grigoriadis Dimitri E. | Chief Research Officer | Sell | 10,000 | $55.00 | $550,000.00 | -7.8% | |
| May 1, 2017 | Gano Kyle | Chief Business Development Off | Sale+OE | 15,000 | $54.00 | $810,000.00 | -17.0% |